The use of simvastatin for the prevention of gallstones in the lithogenic prairie dog model

被引:24
作者
Davis, KG [1 ]
Wertin, TM [1 ]
Schriver, JP [1 ]
机构
[1] William Beaumont Army Med Ctr, Dept Gen Surg, El Paso, TX 79920 USA
关键词
lithogenic diet; simvastatin; cholelithiasis; prairie dog; morbid obesity;
D O I
10.1381/096089203322618678
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Surgery for morbid obesity is rapidly increasing. Patients undergoing bariatric surgery are prone to gallstone development during the rapid weight loss. These patients are often given medications such as ursodeoxycholic acid to prevent gallstone formation; however, these medications are often poorly tolerated by patients, who subsequently discontinue them. We performed a study in a lithogenic animal model to assess the effectiveness of a potential alternate medication for gallstone prevention. Methods: 20 male prairie dogs were randomly separated into 2 groups and fed a lithogenic diet for 28 days. The study group animals were given 2.5 mg of the HMG-CoA reductase inhibitor simvastatin. Total cholesterol and triglycerides were measured and an open cholecystectomy was performed on each animal at the conclusion of the study period. The gallbladder was visually inspected for gallstones and microscopic biliary cholesterol crystal formation. Results: There was a decrease of 36% in the total cholesterol of the study animals compared to controls. The animals treated with simvastatin showed gallstone formation in 5/10 (50%) of animals, compared with 6/10 (60%) of control animals. The study animals demonstrated microscopic cholesterol crystal formation in 80%, identical to the number found in the control animals. Conclusion: Despite a reduction in cholesterol, simvastatin prevented neither gallstone formation nor biliary cholesterol crystals in this animal model. Given the rapid increase in the number of bariatric surgical procedures coupled with the poor tolerance of ursodeoxycholic acid, viable alternatives should continue to be sought for these patients.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 13 条
[1]   EFFECTS OF OBESITY AND CALORIC INTAKE ON BILIARY LIPID-METABOLISM IN MAN [J].
BENNION, LJ ;
GRUNDY, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (04) :996-1011
[2]   Overview of bariatric surgery [J].
Buchwald, H .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (03) :367-375
[3]   EFFECTS OF CHENODEOXYCHOLIC AND URSODEOXYCHOLIC ACIDS ON LIPID-METABOLISM AND GALLSTONE FORMATION IN THE PRAIRIE DOG [J].
COHEN, BI ;
SINGHAL, AK ;
STENGER, RJ ;
MAYDONATH, P ;
FINVERSADOWSKY, J ;
MCSHERRY, CK ;
MOSBACH, EH .
HEPATOLOGY, 1984, 4 (02) :300-307
[4]   Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: Is it worth the wait? [J].
Hamad, GG ;
Ikramuddin, S ;
Gourash, WF ;
Schauer, PR .
OBESITY SURGERY, 2003, 13 (01) :76-81
[5]  
HOLZBACH R, 1984, HEPATOLOGY, V4, P1915
[6]   Gallbladder management in obesity surgery [J].
Mason, EE ;
Renquist, KE ;
Angus, LDG ;
Baker, DJ ;
Baker, JW ;
Betcher, RA ;
Cleator, AGM ;
Clough, DM ;
Cox, S ;
Doherty, C ;
Drew, R ;
Ediger, AJ ;
Fobi, MAL ;
Gleysteen, JJ ;
Halverson, JD ;
Jaroch, MT ;
Jones, KB ;
Lee, H ;
LePort, P ;
Lirio, OC ;
MacPherson, BH ;
Maher, JW ;
Marema, RI ;
Mason, EE ;
Murphy, LJ ;
Popoola, D ;
Rumsey, EW ;
Rupp, W ;
Schechner, SA ;
Schwartz, M ;
Scott, TC ;
Stoner, JA ;
Tanaka, LK ;
Zorn, GG .
OBESITY SURGERY, 2002, 12 (02) :222-229
[7]   National trends in utilization and in-hospital outcomes of bariatric surgery [J].
Pope, GD ;
Birkmeyer, JD ;
Finlayson, SRG .
JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (06) :855-860
[8]   LOVASTATIN INHIBITS GALLSTONE FORMATION IN THE CHOLESTEROL-FED PRAIRIE DOG [J].
SAUNDERS, KD ;
CATES, JA ;
ABEDIN, MZ ;
REGE, S ;
FESTEKDJIAN, SF ;
HOWARD, W ;
ROSLYN, JJ .
ANNALS OF SURGERY, 1991, 214 (02) :149-154
[9]   Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones [J].
Smith, JL ;
Roach, PD ;
Wittenberg, LN ;
Riottot, M ;
Pillay, SP ;
Nestel, PJ ;
Nathanson, LK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (08) :871-879
[10]   A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE TRIAL OF PROPHYLACTIC URSODIOL FOR THE PREVENTION OF GALLSTONE FORMATION FOLLOWING GASTRIC-BYPASS-INDUCED RAPID WEIGHT-LOSS [J].
SUGERMAN, HJ ;
BREWER, WH ;
SHIFFMAN, ML ;
BROLIN, RE ;
FOBI, MAL ;
LINNER, JH ;
MACDONALD, KG ;
MACGREGOR, AM ;
MARTIN, LF ;
ORAMSMITH, JC ;
POPOOLA, D ;
SCHIRMER, BD ;
VICKERS, FF .
AMERICAN JOURNAL OF SURGERY, 1995, 169 (01) :91-97